Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 2,050 | 1,101 | 317 | 317 | 0 |
| Gross Profit | 2,050 | 1,101 | 317 | 317 | N/A |
| Operating Expenses | 66,346 | 55,787 | 48,280 | 30,137 | 13,435 |
| Operating Income | -64,296 | -54,686 | -47,963 | -29,820 | -13,435 |
| Interest Expense | 1 | 0 | 0 | 0 | 0 |
| Other Income | 2,018 | 676 | 220 | 2 | 4 |
| Pre-tax Income | -62,279 | -54,010 | -47,743 | -29,818 | -13,431 |
| Net Income Continuous | -62,279 | -54,010 | -47,743 | -29,818 | -13,431 |
| Net Income | $-62,279 | $-54,010 | $-47,743 | $-29,818 | $-13,431 |
| EPS Basic Total Ops | -19.10 | -21.30 | -40.50 | -175.50 | -102.60 |
| EPS Basic Continuous Ops | -19.07 | -21.26 | -37.60 | -150.60 | -88.07 |
| EPS Diluted Total Ops | -19.10 | -21.30 | -40.50 | -175.50 | -102.60 |
| EPS Diluted Continuous Ops | -19.07 | -21.26 | -37.60 | -150.60 | -88.07 |
| EPS Diluted Before Non-Recurring Items | -19.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-62,692 | $-53,159 | $-46,690 | $-29,218 | $-13,177 |